These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 9818739)

  • 1. Transferable class C beta-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC beta-lactamase.
    Gazouli M; Tzouvelekis LS; Vatopoulos AC; Tzelepi E
    J Antimicrob Chemother; 1998 Oct; 42(4):419-25. PubMed ID: 9818739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2).
    Gazouli M; Tzouvelekis LS; Prinarakis E; Miriagou V; Tzelepi E
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1736-40. PubMed ID: 8807075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTX-m-3 beta-lactamase-producing Escherichia coli from Greece.
    Mavroidi A; Tzelepi E; Miriagou V; Gianneli D; Legakis NJ; Tzouvelekis LS
    Microb Drug Resist; 2002; 8(1):35-7. PubMed ID: 12002647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible expression of the chromosomal cdiA from Citrobacter diversus NF85, encoding an ambler class A beta-lactamase, is under similar genetic control to the chromosomal ampC, encoding an ambler class C enzyme, from Citrobacter freundii OS60.
    Jones ME; Bennett PM
    Microb Drug Resist; 1995; 1(4):285-91. PubMed ID: 9158798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland.
    Literacka E; Empel J; Baraniak A; Sadowy E; Hryniewicz W; Gniadkowski M
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4136-43. PubMed ID: 15504832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis.
    Verdet C; Arlet G; Ben Redjeb S; Ben Hassen A; Lagrange PH; Philippon A
    FEMS Microbiol Lett; 1998 Dec; 169(2):235-40. PubMed ID: 9868767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFE-1, a novel plasmid-encoded AmpC beta-lactamase with an ampR gene originating from Citrobacter freundii.
    Nakano R; Okamoto R; Nakano Y; Kaneko K; Okitsu N; Hosaka Y; Inoue M
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1151-8. PubMed ID: 15047515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel CMY-2-type β-lactamases encountered in clinical Escherichia coli isolates.
    Manageiro V; Ferreira E; Pinto M; Fonseca F; Ferreira M; Bonnet R; Caniça M
    Ann Clin Microbiol Antimicrob; 2015 Mar; 14():12. PubMed ID: 25885413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of CFE-2, a new plasmid-encoded AmpC β-lactamase from a clinical isolate of Citrobacter freundii.
    Chen CM; Huang M; Wu HJ; Guo MK; Wu LT
    Int J Antimicrob Agents; 2018 Sep; 52(3):421-424. PubMed ID: 29944954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins.
    Bauernfeind A; Wagner S; Jungwirth R; Schneider I; Meyer D
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2041-6. PubMed ID: 9303413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and sequencing of the beta-lactamase gene and surrounding DNA sequences of Citrobacter braakii, Citrobacter murliniae, Citrobacter werkmanii, Escherichia fergusonii and Enterobacter cancerogenus.
    Naas T; Aubert D; Fortineau N; Nordmann P
    FEMS Microbiol Lett; 2002 Sep; 215(1):81-7. PubMed ID: 12393205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and sequencing of the gene encoding the AmpC beta-lactamase of Morganella morganii.
    Barnaud G; Arlet G; Danglot C; Philippon A
    FEMS Microbiol Lett; 1997 Mar; 148(1):15-20. PubMed ID: 9066104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origin and evolution of the AmpC beta-lactamases of Citrobacter freundii.
    Barlow M; Hall BG
    Antimicrob Agents Chemother; 2002 May; 46(5):1190-8. PubMed ID: 11959544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasmid-mediated cephalosporinase among extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae].
    Wang QT; Liu YM; Wang H; Sun HL; Chen MJ; Du XL
    Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):487-90. PubMed ID: 15312399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-spectrum beta-lactam resistance due to AmpC hyperproduction and CMY-2 coupled with the loss of OMPK35 in Malaysian strains of Escherichia coli and Klebsiella pneumoniae.
    Palasubramaniam S; Subramaniam G; Muniandy S; Parasakthi N
    Microb Drug Resist; 2007; 13(3):186-90. PubMed ID: 17949305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type beta-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC beta-lactamase.
    Wu SW; Dornbusch K; Kronvall G; Norgren M
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1350-7. PubMed ID: 10348751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased production of AmpC-type beta-lactamases associated with the development of resistance to quinolones in Citrobacter freundii strains.
    Tavío Pérez MM; Amicosante G; Franceschini N; Vila J; Ruiz J; Oratore A; Martín-Sánchez AM; Jiménez de Anta MT
    Microb Drug Resist; 1999; 5(4):235-40. PubMed ID: 10647079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMY-20, a novel AmpC-type beta-lactamase from South African clinical Escherichia coli isolates.
    Mocktar C; Govinden U; Sturm AW; Essack SY
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):405-8. PubMed ID: 18207348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
    Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.
    Dahyot S; Mammeri H
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1151-6. PubMed ID: 22232281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.